ARCHIVES

Study Would Try to Validate EGFR FISH as Predictive Marker for Benefit from Tarceva.

This article is from The Cancer Letter archive.

Vol. 33 No. 27 | July 13, 2007

Download PDF Visit The Full Archive

Related Articles

Three Community Based Programs Slated for Early Phaseout, Others Modified, Provided NCAB Agrees

February 29, 1980

Bennett, Federal Prosecutors Reach $475,000 Settlement

October 31, 2014

NCI Awards $15M For Studies Of Glycobiology.

September 28, 2007

NCI Intramural Programs: Clinical Trials Support System Need Attention, report Advises DCS

December 19, 1997

PR Firm Hired By American Cancer Society Also Represents “Team KOOL Green”.

January 28, 2000

Bush Signs Bill To Increase Blood Cancer Research.

May 17, 2002